/index.php?option=com_iwpfile&file=/dir_01/he2003_0708.pdf


/index.php?option=com_iwpfile&file=/dir_01/he2003_0707.pdf


/index.php?option=com_iwpfile&file=/dir_01/he2003_0706.pdf


Dooley Bill Dooley Bill Summary Emmanuel Statement Dooley Statement Davis Statement


/index.php?option=com_iwpfile&file=/dir_01/he2003_0704.pdf


/index.php?option=com_iwpfile&file=/dir_01/he2003_0703.pdf


ension

FDA has issued a guidance entitled, "Guidance for Federal Agencies, and State and Local Governments - Potassium Iodide Tablets Shelf Life Extension" on how to conduct drug testing to determine the shelf life of stockpiled potassium iodide (KI) tablets. These methods could verify the continued viability of these drugs when stored under controlled conditions. KI is a treatment for radiation poisoning after a nuclear attack.


Critical Infrastructure Critical Infrastructure -- GAO Report


FACE="Times New Roman">Medicare Prescription Drug Benefit

The Subcommittee on Health has scheduled a hearing on Tuesday, April 8, 2003, at 10:00 a.m. in 2123 Rayburn House Office Building, on "Designing a Twenty-First Century Medicare Prescription Drug Benefit."

This event will be open to the public and webcast live. For the latest information, please visit

http://energycommerce.house.gov/108/Hearings/04082003hearing863/hearing.htm


/index.php?option=com_iwpfile&file=/dir_01/he2003_0699.pdf


Pages

Log in to access this content.

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.